{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:14:16Z","timestamp":1789683256419,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.euroneuro.2015.02.012","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T20:21:57Z","timestamp":1429561317000},"page":"808-816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST)"],"prefix":"10.1016","volume":"25","author":[{"given":"G.H.M.","family":"Pijnenborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.","family":"Fleischhacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.02.012_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0920-9964(92)90003-N","article-title":"Reliability and validity of a depression rating scale for schizophrenics","volume":"6","author":"Addington","year":"1992","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib2","series-title":"Insight and Psychosis","author":"Amador","year":"1998"},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2015.02.012_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2009.04.005","article-title":"Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study)","volume":"113","author":"Baeza","year":"2009","journal-title":"Schizophr. Res."},{"issue":"1-2","key":"10.1016\/j.euroneuro.2015.02.012_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.psychres.2014.03.022","article-title":"Effects of antipsychotic drugs on insight in schizophrenia","volume":"218","author":"Bianchini","year":"2014","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2015.02.012_bib500","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/oti.226","article-title":"TRIP: a psycho-educational programme in Hong Kong for people with schizophrenia","volume":"14","author":"Chan","year":"2007","journal-title":"Occup. Therapy Int."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib501","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pec.2008.08.028","article-title":"Evaluation of a psychoeducation program for Chinese clients with schizophrenia and their family caregivers","volume":"75","author":"Chan","year":"2009","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0447.2005.00620.x","article-title":"Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder","volume":"112","author":"Crumlish","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1192\/bjp.156.6.798","article-title":"Insight and psychosis","volume":"156","author":"David","year":"1990","journal-title":"Br. J. Psychiatry."},{"issue":"1","key":"10.1016\/j.euroneuro.2015.02.012_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4088\/JCP.v68n0111","article-title":"Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England","volume":"68","author":"Drake","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.02.012_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2005.06.004","article-title":"The European first episode schizophrenia trial (EUFEST): rationale and design of the trial","volume":"78","author":"Fleischhacker","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0447.1993.tb03366.x","article-title":"The St. Hans rating scale for extrapyramidal syndromes: reliability and validity","volume":"87","author":"Gerlach","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1176\/appi.ajp.162.3.520","article-title":"A randomised controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia","volume":"162","author":"Granholm","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2015.02.012_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archgenpsychiatry.2010.105","article-title":"Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia","volume":"67","author":"Guo","year":"2010","journal-title":"Arch . Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.02.012_bib12","series-title":"Handbook of Psychiatric Measures","first-page":"100","article-title":"Clinical global impressions (CGI) scale","author":"Guy","year":"2000"},{"key":"10.1016\/j.euroneuro.2015.02.012_bib13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.166.5.654","article-title":"A brief mental health outcome scale-reliability and validity of the global assessment of functioning (GAF)","volume":"166","author":"Jones","year":"1995","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.02.012_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eurpsy.2005.05.015","article-title":"A prospective evaluation of adherence to medication in first episode schizophrenia","volume":"21","author":"Kamali","year":"2006","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.02.012_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2710.2010.01230.x","article-title":"Insight change and its relationship to subjective well-being during acute atypical antipsychotic treatment in schizophrenia","volume":"36","author":"Kim","year":"2011","journal-title":"J. Clin. Pharm. Ther."},{"issue":"9618","key":"10.1016\/j.euroneuro.2015.02.012_bib16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder. an open randomised trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.euroneuro.2015.02.012_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.euroneuro.2015.02.012_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/JCP.0b013e3181b2fe22","article-title":"Effects of aripiprazole on insight and subjective experience in individuals with an at-risk mental state","volume":"29","author":"Kobayashi","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2015.02.012_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.schres.2013.10.013","article-title":"The nature and evolution of insight in schizophrenia: a multi-informant longitudinal study of first-episode versus chronic patients","volume":"151","author":"Koren","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/schbul\/sbm002","article-title":"Correlates and long-term consequences of poor insight in patients with schizophrenia. a systematic review","volume":"33","author":"Lincoln","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/00332747.1994.11024695","article-title":"Insight and psychosocial treatment compliance in schizophrenia","volume":"57","author":"Lysaker","year":"1994","journal-title":"Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.02.012_bib24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1017\/S0033291706007793","article-title":"Insight in first-episode psychosis","volume":"36","author":"McEvoy","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s001270050146","article-title":"Patient and relative education in community psychiatry: A randomized controlled trial regarding its effectiveness","volume":"34","author":"Merinder","year":"1999","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"1","key":"10.1016\/j.euroneuro.2015.02.012_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0920-9964(02)00316-X","article-title":"Insight in schizophrenia: a meta-analysis","volume":"61","author":"Mintz","year":"2003","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2015.02.012_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-1781(99)00033-5","article-title":"Effects of clozapine on awareness of illness and cognition in schizophrenia","volume":"86","author":"Pallanti","year":"1999","journal-title":"Psychiatry Res."},{"issue":"9","key":"10.1016\/j.euroneuro.2015.02.012_bib28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1017\/S0033291708004868","article-title":"Insight correlates in child- and adolescent-onset first episodes of psychosis: results from the CAFEPS study","volume":"39","author":"Parellada","year":"2009","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.euroneuro.2015.02.012_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/schbul\/sbq109","article-title":"Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study","volume":"37","author":"Parellada","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0447.2010.01572.x","article-title":"A randomised controlled trial of cognitive behaviour therapy for psychosis in a routine clinical service","volume":"122","author":"Peters","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2012.11.018","article-title":"Treating insight in psychosis: a meta-analysis","volume":"144","author":"Pijnenborg","year":"2013","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.euroneuro.2015.02.012_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00406-012-0373-0","article-title":"Insight into schizophrenia: associations with theory of mind, subjective empathy and emotion perception","volume":"263","author":"Pijnenborg","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/002076409904500102","article-title":"Application and results of the manchester short assessment of quality of life (MANSA)","volume":"45","author":"Priebe","year":"1999","journal-title":"Int. J. Soc. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2015.02.012_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/schbul\/sbq133","article-title":"Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness","volume":"37","author":"Quee","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/acps.12138","article-title":"Insight change in patients with psychotic disorders: relationship with neurocognition, social cognition, clinical symptoms and phase of illness","volume":"129","author":"Quee","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib36","series-title":"A User\u05f3s Guide to MLwiN","author":"Rabash","year":"2009"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2015.02.012_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.schres.2006.09.018","article-title":"The association of insight with psychotic symptoms, depression, and cognition in early psychosis: a 3-year follow-up","volume":"89","author":"Saeedi","year":"2007","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2015.02.012_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1017\/S0033291797006296","article-title":"A comparative study of insight scales and their relationship to psychopathological and clinical variables","volume":"28","author":"Sanz","year":"1998","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.euroneuro.2015.02.012_bib39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.eurpsy.2012.01.001","article-title":"Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder","volume":"27","author":"Schennach","year":"2012","journal-title":"Eur. Psychiatry"},{"issue":"Suppl. 20","key":"10.1016\/j.euroneuro.2015.02.012_bib40","first-page":"S22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheenan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2015.02.012_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11126-009-9103-9","article-title":"Insight, global functioning and psychopathology amongst in-patient clients with schizophrenia","volume":"80","author":"Stefanopoulou","year":"2009","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.euroneuro.2015.02.012_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/bjp.bp.105.010884","article-title":"Outcomes of an effectiveness trial of cognitive behavioral intervention by mental health nurses in schizophrenia","volume":"189","author":"Turkington","year":"2006","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2015.02.012_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3371\/CSRP.4.3.3","article-title":"Insight: demographic differences and associations with one-year outcome in schizophrenia and schizoaffective disorder","volume":"4","author":"Wiffen","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"6","key":"10.1016\/j.euroneuro.2015.02.012_bib45","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/schbul\/sbs122","article-title":"Insight in schizophrenia: involvement of self-reflection networks?","volume":"39","author":"Van der Meer","year":"2013","journal-title":"Schizophr. Bull."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:51:49Z","timestamp":1760377909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0924977X15000450"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.02.012","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST)","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}